Crescent BiopharmaCBIO
13F holders, Q4 2025 (December 31)2holders
$11.86avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Crescent Biopharma Inc. (CBIO) in their 13F filings. The largest holders were Remedium Capital Partners, LLC ($4.3M) and Quadrature Capital Ltd ($157K).
- Company
- Crescent Biopharma Inc.
- CUSIP
- 38000Q201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $157K |
| Exits | 0 | $0 |
Ownership 2 holders
| Remedium Capital Partners, LLC | 2.52% | — | 361,250 | $4.3M |
| Quadrature Capital Ltd | 0.00% | New | 13,246 | $157K |
"% of holder's portfolio" is CBIO's weight in each manager's 13F, not the share of Crescent Biopharma Inc. the manager owns.